FOF/VC  Terra Magnum Capital Partners

http://www.terramagnumcap.com/





     Office Locations:

4701 Sangamore Rd., Ste 100N - 1018
Bethesda, MD 20816

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 2016 with over $800 million assets under management, Terra Magnum Capital Partners (TMCP) specializes in both direct investments and fund investments. TMCP's team is composed of individuals with investment, operations and management experience in global private equity fund of funds, local private equity funds, investment banks as well as regulatory bodies. The firm currently has multiple funds managed in USD and RMB, with offices in United States and China.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Ben Wang Partner & COO
    Frank Qin Partner
    Ray Yang Partner
    Sha Wang Founding Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/17/2022


      Walking Fish Therapeutics


      CA


      $23,000,000


      Series A


     

    Portfolio companies include:


      Erasca
        web link


      Maze Therapeutics
        web link


      RNAimmune
        web link


      ShouTi
        web link


      Walking Fish Therapeutics
        web link


     

    Recent News: